Your browser doesn't support javascript.
loading
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease.
Bolla, Michel; Neven, Anouk; Maingon, Philippe; Carrie, Christian; Boladeras, Ana; Andreopoulos, Demetrios; Engelen, Antoine; Sundar, Santhanam; van der Steen-Banasik, Elzbieta M; Armstrong, John; Peignaux-Casasnovas, Karine; Boustani, Jihane; Herrera, Fernanda G; Pieters, Bradley R; Slot, Annerie; Bahl, Amit; Scrase, Christopher D; Azria, David; Jansa, Jan; O'Sullivan, Joe M; Van Den Bergh, Alphonsus C M; Collette, Laurence.
Affiliation
  • Bolla M; Radiotherapy Department Grenoble, Grenoble Alpes University, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
  • Neven A; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Maingon P; Sorbonne University, APHP Sorbonne University, La Pitié Salpêtrière, Paris, France.
  • Carrie C; Radiotherapy Department, Leon Bérard Center, Lyon, France.
  • Boladeras A; Radiation Oncology Department, Catalan Institute of Oncology-University Hospital Germans Trias I Pujol, Badalona, Barcelona, Catalonia, Spain.
  • Andreopoulos D; Radiotherapy Department, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
  • Engelen A; Institute Verbeeten, Tilburg, the Netherlands.
  • Sundar S; Nottingham University Hospitals NHS Trust-City Hospital, Consultant Medical Oncologist, Nottingham, United Kingdom.
  • van der Steen-Banasik EM; Radiotherapiegroep Arnhem, Arnhem, the Netherlands.
  • Armstrong J; Radiation Oncology Department, All Ireland Cooperative Oncology Research Group, St Luke's Hospital, Dublin, Ireland.
  • Peignaux-Casasnovas K; Radiotherapy Department, Georges-Francois-Leclerc Centre, Dijon, France.
  • Boustani J; Radiotherapy Department, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France.
  • Herrera FG; Radiation Oncology and Immuno-Oncology Service, University Hospital of Lausanne, Lausanne, Switzerland.
  • Pieters BR; Department of Radiation Oncology, Amsterdam University Medical Centers/University of Amsterdam, Amsterdam, the Netherlands.
  • Slot A; Radiotherapeutisch Instituut Friesland, Leeuwarden, the Netherlands.
  • Bahl A; University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon, United Kingdom.
  • Scrase CD; Ipswich Hospital National Health Services Trust, Ipswich, United Kingdom.
  • Azria D; Institut du Cancer de Montpellier, Université de Montpellier, INSERM U1194, Montpellier, France.
  • Jansa J; Klinika Onkologie a Radioterapie-Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czech Republic.
  • O'Sullivan JM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Ireland.
  • Van Den Bergh ACM; Radiotherapy Department, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Collette L; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
J Clin Oncol ; 39(27): 3022-3033, 2021 09 20.
Article in En | MEDLINE | ID: mdl-34310202
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Androgen Antagonists Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Androgen Antagonists Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos